Pill halves risk of endometrial cancer

Use of combined oral contraceptives halves a woman's lifetime risk of endometrial cancer, a major review suggests.

Cancer researchers have made the claim based on the pooling of epidemiological data from 27,000 women with endometrial cancer.

In a review published in Lancet Oncology, they report that every five years of oral contraceptive use is associated with a 24% reduction in relative risk of endometrial cancer, and the reduction in risk increases with the duration of oral contraceptive use.

The researchers estimate that using oral contraceptives for 10 years

Latest

Trending